Larson Financial Group’s Iterum Therapeutics ITRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13
| Closed | -$20 | – | 2454 |
|
|
2024
Q1 | $20 | Hold |
13
| – | – | ﹤0.01% | 1767 |
|
|
2023
Q4 | $26 | Hold |
13
| – | – | ﹤0.01% | 1766 |
|
|
2023
Q3 | $10 | Hold |
13
| – | – | ﹤0.01% | 1696 |
|
|
2023
Q2 | $14 | Hold |
13
| – | – | ﹤0.01% | 1552 |
|
|
2023
Q1 | $13 | Hold |
13
| – | – | ﹤0.01% | 1532 |
|
|
2022
Q4 | $11 | Hold |
13
| – | – | ﹤0.01% | 1493 |
|
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 1346 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 1238 |
|
|
2022
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 1101 |
|
|
2021
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 1120 |
|
|
2021
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 913 |
|
|
2021
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 873 |
|
|
2021
Q1 | $0 | Buy |
+13
| New | – | ﹤0.01% | 882 |
|